Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Agenus, a leader in immuno-oncology, announced that CEO Dr. Garo Armen and Chief Commercial Officer Robin Taylor will participate in the Goldman Sachs 45th Annual Global Healthcare Conference. This event will be held from June 10-13 in Miami Beach, Florida. A fireside chat featuring both executives will occur at 8:00 a.m. ET on June 12. The chat will be available via live webcast and replay on the company's website. Agenus focuses on developing immunological agents to treat cancer and infectious diseases. Their approach includes a pipeline of antibody therapeutics and adoptive cell therapies. The company is based in Lexington, MA.

Positive

• Agenus' participation in a high-profile healthcare conference increases visibility and credibility.
• A live webcast of the fireside chat ensures broader access to important company updates.
• Agenus has a comprehensive pipeline focusing on cancer and infectious diseases, which could attract investor interest.

Negative

• The announcement lacks concrete data on financial performance or clinical milestones.
• There is no mention of any new partnerships or collaborations which could be important for growth.
• Investors may be concerned about a lack of immediate actionable updates from the conference.

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (“Agenus”) (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, and Robin Taylor, Chief Commercial Officer, will participate in a fireside chat and investor one-on-ones at the upcoming Goldman Sachs Global Healthcare Conference on June 10^th – 13^th in Miami Beach, Florida. The fireside chat will take place at 8:00 a.m. ET on June 12^th.

A live webcast and replay of the fireside chat will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations/.

About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523361904/en/

Investor

917-362-1370

investor@agenusbio.com

Media

612-839-6748

communications@agenusbio.com

Source: Agenus Inc.

FAQ

When is Agenus participating in the Goldman Sachs Global Healthcare Conference?

Agenus will participate in the Goldman Sachs 45th Annual Global Healthcare Conference from June 10-13, 2023.

Who from Agenus will participate in the Goldman Sachs Healthcare Conference?

Dr. Garo Armen, Chairman and CEO, and Robin Taylor, Chief Commercial Officer, will represent Agenus.

When is the fireside chat for Agenus at the Goldman Sachs Conference?

The fireside chat will take place at 8:00 a.m. ET on June 12, 2023.

How can I access a live webcast of Agenus' fireside chat?

The live webcast and replay will be accessible on Agenus' website at https://investor.agenusbio.com/events-and-presentations/.